DEN APOTHEKER: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DEN APOTHEKER
Largest movements
- Tangible fixed assets +€253,993
up €253,993 (+813%), from €31,242 to €285,235
of which Land and buildings: +€251,122
- Receivables within one year -€84,599
down €84,599 (-10.9%), from €776,740 to €692,142
of which Other amounts receivable: -€110,075
- Cash +€64,611
up €64,611 (+33.4%), from €193,569 to €258,180
mainly Other debts (+€250,061) and Net result for the year (+€120,119)
- Other debts +€250,061
up €250,061 (+160%), from €156,279 to €406,340
- Other operating charges +€30,982
up €30,982 (+894%), from €3,466 to €34,448
- Taxes -€12,237
down €12,237 (-22.9%), from €53,353 to €41,116
- Staff costs +€7,038
up €7,038 (+24.6%), from €28,578 to €35,616
- Depreciation +€5,660
up €5,660 (+56.8%), from €9,964 to €15,624
- Gross operating margin -€3,842
down €3,842 (-1.5%), from €254,101 to €250,259
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,455,139 | €1,688,006 | +€232,867 | +16.0% |
| Fixed assets | 21/28 | €31,242 | €285,235 | +€253,993 | +813% |
| Tangible fixed assets | 22/27 | €31,242 | €285,235 | +€253,993 | +813% |
| Land and buildings | 22 | €2,644 | €253,766 | +€251,122 | +9,498% |
| Plant, machinery and equipment | 23 | €17,507 | €24,114 | +€6,607 | +37.7% |
| Furniture and vehicles | 24 | €11,091 | €7,355 | -€3,736 | -33.7% |
| Current assets | 29/58 | €1,423,897 | €1,402,771 | -€21,126 | -1.5% |
| Amounts receivable after more than one year | 29 | €160,000 | €160,000 | = | 0.0% |
| Other amounts receivable | 291 | €160,000 | €160,000 | = | 0.0% |
| Stocks and contracts in progress | 3 | €180,041 | €175,310 | -€4,731 | -2.6% |
| Stocks | 30/36 | €180,041 | €175,310 | -€4,731 | -2.6% |
| Amounts receivable within one year | 40/41 | €776,740 | €692,142 | -€84,599 | -10.9% |
| Trade receivables | 40 | €95,898 | €121,374 | +€25,476 | +26.6% |
| Other amounts receivable | 41 | €680,843 | €570,767 | -€110,075 | -16.2% |
| Current investments | 50/53 | €87,682 | €87,682 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €193,569 | €258,180 | +€64,611 | +33.4% |
| Deferred charges and accrued income | 490/1 | €25,865 | €29,458 | +€3,593 | +13.9% |
| Total equity and liabilities | 10/49 | €1,455,139 | €1,688,006 | +€232,867 | +16.0% |
| Equity | 10/15 | €1,202,144 | €1,202,144 | = | 0.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,183,544 | €1,183,544 | = | 0.0% |
| Non-distributable reserves | 130/1 | €29,360 | €29,360 | = | 0.0% |
| Reserves not available under the articles | 1311 | €29,360 | €29,360 | = | 0.0% |
| Tax-exempt reserves | 132 | €56,250 | €56,250 | = | 0.0% |
| Distributable reserves | 133 | €1,097,934 | €1,097,934 | = | 0.0% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €252,995 | €485,861 | +€232,867 | +92.0% |
| Amounts payable within one year | 42/48 | €251,131 | €484,893 | +€233,761 | +93.1% |
| Current portion of amounts payable after more than one year | 42 | €525 | €645 | +€120 | +22.9% |
| Trade debts | 44 | €76,992 | €73,188 | -€3,803 | -4.9% |
| Suppliers | 440/4 | €76,992 | €73,188 | -€3,803 | -4.9% |
| Taxes, remuneration and social security | 45 | €17,336 | €4,720 | -€12,616 | -72.8% |
| Taxes | 450/3 | €13,353 | €0 | -€13,353 | -100% |
| Remuneration and social security | 454/9 | €3,983 | €4,720 | +€737 | +18.5% |
| Other amounts payable | 47/48 | €156,279 | €406,340 | +€250,061 | +160% |
| Accrued charges and deferred income | 492/3 | €1,863 | €969 | -€894 | -48.0% |
| Remuneration, social security and pensions | 62 | €28,578 | €35,616 | +€7,038 | +24.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,964 | €15,624 | +€5,660 | +56.8% |
| Other operating charges | 640/8 | €3,466 | €34,448 | +€30,982 | +894% |
| Gross operating margin | 9900 | €254,101 | €250,259 | -€3,842 | -1.5% |
| Operating profit (loss) | 9901 | €212,093 | €164,572 | -€47,521 | -22.4% |
| Financial income | 75/76B | €40 | €161 | +€121 | +299% |
| Recurring financial income | 75 | €40 | €161 | +€121 | +299% |
| Financial charges | 65/66B | €2,948 | €3,498 | +€550 | +18.6% |
| Recurring financial charges | 65 | €2,948 | €3,498 | +€550 | +18.6% |
| Profit (loss) for the period before taxes | 9903 | €209,185 | €161,235 | -€47,950 | -22.9% |
| Income taxes | 67/77 | €53,353 | €41,116 | -€12,237 | -22.9% |
| Profit (loss) for the period | 9904 | €155,832 | €120,119 | -€35,713 | -22.9% |
| Profit (loss) for the period to be appropriated | 9905 | €155,832 | €120,119 | -€35,713 | -22.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.